Modular high-throughput platform for the purification of scFvs and multispecific antibody-based therapeutics
Automated ÄKTA system-based purification protocols were developed to streamline and accelerate protein production of single-chain variable fragments and multispecific antibodies. The protocols utilize ASX-560 and ALIAS autosampler systems to automate sample injections during overnight and idling times and incorporate one-, two- and three-column schemes to facilitate purification workflows. Additionally, the novel membrane affinity chromatography technology was employed to decrease residence times by increasing flowrates, shortening purification method run time per cycle. As a result, the implementation of versatile and automated multi-column purification protocols enabled the cost-effective and rapid capture of up to 51 single-chain variable fragments per day with high monomeric purities >90 %. Automated affinity chromatography protocols facilitated the daily purification of up to 22 multispecific antibodies. To increase the monomeric target purity of selected single-chain variable fragments and multispecific antibodies, size-exclusion chromatography was automated using the ALIAS Bio PREP autosampler system, enabling the polishing of up to 15 single-chain variable fragments or multispecific antibodies per day.
Authors
- Ronnie Palmgren
- Stefan Warmuth (ORCID: https://orcid.org/0000-0001-6872-8805)
- Bastian Franke (ORCID: https://orcid.org/0000-0001-8029-4069)
- Christian Hess (ORCID: https://orcid.org/0009-0006-4556-6288)
- Julien Québatte
- Sebastian Wolniak
- Amélie Terreaux
- Cheryl Erne
Institutions
- Straumann (Switzerland) (CH)
- NewGen Therapeutics (United States) (US)
Publication Details
- Journal
- Journal of Chromatography A
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1016/j.chroma.2025.466096
- Citations
- 1
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 1.36